Recent Finacing
Recent Raise
引正基因 is a platform technology company developing next-generation CRISPR-based gene-editing tools that improve editing efficiency and precision while reducing off-target effects.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at GenEditBio.
